Duopharma to supply 6.4 million doses of Sputnix V vaccine 


KUALA LUMPUR: Duopharma Biotech Bhd has entered into a deal to supply the Ministry of Health with 6.4 million doses of Covid-19 vaccine developed by Russia.

The supply is subject to the “Sputnik V” vaccine being approved by Drug Control Authority, Malaysia through technical evaluation by the National Pharmaceutical Regulatory Agency.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Duopharma Biotech , vaccine , Sputnix V

   

Next In Business News

Etiquette at an open house
Trump’s presidency a boon
Elevating outdoor oases
GDA stands firm on RM11 offer for MAHB despite directors' rejection
Ringgit expected to trade within narrow range next week amid holiday calm
Oil steady as markets weigh Fed rate-cut expectations
The beauty of Hygr’s formula
Top Glove bullish on outlook amid steady order inflows
US market - prudence is golden
Book speaks volumes about Penang food

Others Also Read